# A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer

> **NCT02990468** · PHASE1,PHASE2 · COMPLETED · sponsor: **BioMimetix JV, LLC** · enrollment: 29 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **DRUG:** BMX-001
- **RADIATION:** Radiation Therapy
- **DRUG:** Cisplatin

## Key facts

- **NCT ID:** NCT02990468
- **Lead sponsor:** BioMimetix JV, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-19
- **Primary completion:** 2020-02-21
- **Final completion:** 2022-03-31
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2023-03-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02990468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02990468, "A Trial of Concurrent Radiation Therapy, Cisplatin, and BMX-001 in Locally Advanced Head and Neck Cancer". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT02990468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*